ABSTRACT -Omeprazole (OPZ) and β-naphthoflavone (BNF) are cytochrome P450 (CYP)1A inducers and have liver tumor promoting effects. In this study, we investigated the co-promoting and co-initiating effects of OPZ and BNF in rats. In Experiment 1, male rats were subjected to partial hepatectomy (PH), and given oral doses of 138 or 276 mg/kg OPZ, 0.125% or 0.25% BNF or 138 mg/kg OPZ+0.125% BNF (n = 9~12) for 6 weeks after N-diethylnitrosamine (DEN) initiation. In Experiment 2, male rats were treated with oral doses of 138 or 276 mg/kg OPZ, 0.03% or 0.06% BNF or 138 mg/kg OPZ+0.03% BNF (n = 11~12) for 9 days starting 1 week before initiating treatment. As an initiating treatment, 2-Amino-3,4-dimethylimidazo[4,5-f]quinolone (MeIQx) was orally administered 12 hr after PH. The rats were fed a basal diet for 15 days, followed by a diet containing 0.015% 2-acetylaminofluorene for the next 10 days with a single oral dose of carbon tetrachloride. In Experiment 1, the number and area of glutathione S-transferase placental form-positive foci in the OPZ+BNF group were significantly higher than the average values of the High OPZ or the High BNF group. The expression of cyclooxygenase-2 (Cox-2) and COX-2 protein in the liver significantly increased in the OPZ+BNF group. In Experiment 2, liver initiation activity was not enhanced by the co-administration of OPZ+BNF. The results of our studies suggest that the co-administration of OPZ and BNF results in synergistic effects in the liver tumor promotion probably owing to increased COX-2 expression, but no modifying effect in the liver initiation activity of MeIQx in rats.
INTRODUCTION
Cytochrome P450 (CYP) 1A enzymes can be induced by a range of chemicals in a process mediated through the aryl hydrocarbon receptor (AhR) (Ma and Lu, 2007) . Some CYP1A inducers such as 2,3,7,8-tetrachlorodibenzo-dioxin (TCDD) and β-naphthoflavone (BNF) are known to have liver tumor promoting effects in rats and the ability to augment oxidative stress (Kociba et al., 1978; Dewa et al., 2008) . It is generally accepted that microsomal electron systems including CYPs and nicotinamide adenine dinucleotide phosphate (NADPH)-CYP reductase, generate reactive oxygen species (ROS) through metabolism, with the subsequent formation of an oxygenated substrate and water (Poulos and Raag, 1992) . Although electron transfer is normally a well-coupled process, superoxide and H 2 O 2 may be released in the presence of CYP1A inducers that are poorly metabolized.
We have previously demonstrated that some CYP1A inducers such as BNF, indole-3-carbinol and oxfendazole, have liver tumor promoting effects in rats and induce oxidative stress including microsomal ROS generation and thiobarbituric acid-reactive substances (TBARS) production in the liver (Dewa et al., 2008 (Dewa et al., , 2009 Shimamoto et al., 2011a) . We have also shown that a proton pump inhibitor, omeprazole (OPZ), which induces Cyp1a, also Enhanced liver tumor promotion but not liver initiation activity in rats subjected to combined administration of omeprazole and β-naphthoflavone has a liver tumor promoting effect in rats, but oxidative stress is not involved in the mechanism (Hayashi et al., 2012a) . More than 20 mutagenic and carcinogenic heterocyclic amines (HCAs) are produced by cooking or heating meat or fish (Hirata et al., 2008) . 2-Amino-3,4-dimethylimidazo [4,5-f] quinolone (MeIQx) is one of the major HCAs contained in cooked food consumed by humans (Tsuda et al., 1999) , and is thought to be a human liver carcinogen (Lynch et al., 1992) . MeIQx is metabolically activated to genotoxic intermediates by CYP1A2-mediated N-hydroxylation in the liver followed by N-acetyltransferase (NAT)-mediated O-esterification (Kato and Yamazoe, 1987; Yanagawa et al., 1994) . In our previous study, both OPZ and BNF have been shown to induce Cyp1a2 expression in the liver of rats (Dewa et al., 2008; Hayashi et al., 2012b) . Therefore, we speculated that simultaneous treatment of OPZ and BNF modifies MeIQx metabolism and enhances liver initiation activity in rats.
It has been demonstrated that simultaneous exposure to several chemicals at doses lower than the apparent carcinogenic doses results in marked carcinogenic actions in rats (Hasegawa et al., 1989) . In the present, regulatory agency in each country usually sets the acceptable daily intake and maximum residue limit for each chemical in food. However, if simultaneous exposures of plural chemicals enhance their adverse effects and/or initiation activities, we must reconsider the methods of risk evaluation. We think that the evaluation of the effect on combined administration of plural chemicals is beneficial for the risk assessment and risk management of chemicals contained in food. Therefore, we hypothesized that the combined administration of OPZ and BNF: (1) enhances more CYP1A induction resulting in more ROS generation and intensifies the liver tumor promotion effect; or (2) enhances more CYP1A2 induction resulting in more metabolic activation of MeIQx and intensifies the liver initiation effect.
In the present study, we investigated the modifying effect of liver tumor promotion and liver initiation through combined administration of OPZ and BNF in rats, with a particular focus on gene expression and the biochemical events of ROS generation and TBARS production in the liver.
MATERIALS AND METHODS

Chemicals
OPZ , purity 98%), BNF (CAS No. 6051-87-2, purity 98%), MeIQx (CAS No. 77500-04-0, purity 99%) and carbon tetrachloride (CCl 4 ; , purity 99.5%) were purchased from Wako Pure Chemical Industries (Osaka, Japan) . N-Diethylnitrosamine (DEN; CAS No. 55-18-5, purity 99%) and 2-acetylaminofluorene (2-AAF; CAS No.53-96-3, purity 98%) were purchased from Tokyo Kasei Kogyo (Tokyo, Japan).
Animals
Five-week-old male F344 rats used in Experiments 1 and 2 were purchased from Japan SLC Inc. (Shizuoka, Japan), maintained in an air-conditioned room with a 12-hr light/dark cycle (room temperature, 23°C ± 3°C; relative humidity, 55 ± 15%), and given free access to a basal diet (Oriental MF; Oriental Yeast, Tokyo, Japan) and tap water. After a 1-week acclimatization period, the animals were used in these experiments. The animals received humane care, in accordance with the Guide for Animal Experimentation of the Tokyo University of Agriculture and Technology.
Experimental designs Experiment 1
A medium-term liver carcinogenesis bioassay (Ito et al., 2003) was performed according to the following procedure ( Fig. 1) to examine the modification of the liver tumor promoting effect by co-administration of OPZ and BNF. All rats were divided into 6 groups. First, all rats were given an intraperitoneal injection of DEN at a dose of 200 mg/kg body weight, followed by treatment with 0 (DEN alone), 138 mg/kg OPZ (Low OPZ) or 276 mg/kg OPZ (High OPZ) by oral gavage once a day, 0.125% BNF (Low BNF) or 0.25% BNF (High BNF) in diet, or 138 mg/kg OPZ + 0.125% BNF (OPZ+BNF) for 6 weeks starting 2 weeks after DEN treatment. Since the threshold tumor promotion dose of BNF and OPZ is 0.25% and 276 mg/kg, respectively (from our previous research), we adopted half of these doses as the low dose and combination dose in the present study (Hayashi et al., 2012a (Hayashi et al., , 2012b . To enhance hepatocellular proliferation, the rats were subjected to two-thirds partial hepatectomy (PH) at 1 week after the BNF/OPZ treatment was started. The food efficiency in each group was measured during the experiment. At the end of the experiment, the rats were euthanized by exsanguination under ether anesthesia and their livers were excised and weighed. The sliced liver samples were fixed in 10% phosphate-buffered formalin for histopathological and immunohistochemical examinations.
Experiment 2
An in vivo 5-week liver initiation assay was performed according to the method described by Tsuda et al. (1980) . To examine the modification of MeIQx-induced liver tumor initiating effect by co-administration of BNF and OPZ, we modified the duration of this in vivo liver initiation assay to 6 weeks. The experimental design is shown in Fig. 1 . First, all rats were treated with 0 (MeIQx alone), 138 mg/kg OPZ (Low OPZ) or 276 mg/kg OPZ (High OPZ) by oral gavage once a day, 0.03% BNF (Low BNF) or 0.06% BNF (High BNF), or 138 mg/kg OPZ + 0.03% BNF (OPZ+BNF) for 9 days starting 1 week before initiating treatment. The rationale for the dosage was determined based on the results from our previous studies in which 0.06% BNF induced Cyp1a1 and Cyp1a2 expression, being approximately 1923-fold and 8-fold higher than those of the DEN control, and 276 mg/kg OPZ induced Cyp1a1 and Cyp1a2 expression, being approximately 1163-fold and 9-fold higher than those of the DEN control group (Hayashi et al., 2012a (Hayashi et al., , 2012b . As an initiation treatment, 50 mg/kg MeIQx was orally administered 12 hr after PH. One day after the initiation, the rats were fed a basal diet for 15 days, followed by a diet containing 0.015% 2-AAF for 10 days to enhance the tumor-promoting effect. Also, to damage their livers, they were orally administered CCl 4 (0.8 ml/kg bw) dissolved in corn oil on day 29. At the end of the experiment, the rats were euthanized by exsanguination under ether anesthesia and their livers were excised and weighed. The sliced liver samples were fixed in 10% phosphate-buffered formalin for histopathological and immunohistochemical examination.
Histopathology and immunohistochemistry
After formalin fixation of the livers in Experiments 1 and 2, the tissues were dehydrated in graded ethanol and embedded in paraffin. Sections were then mounted onto glass slides and were stained with hematoxylin and eosin or were used for immunohistochemistry analysis. For immunohistochemistry, the horseradish peroxidase avidin-biotin complex method with a Vectastain Elite ABC Fig. 1 . Experimental design of a medium-term liver carcinogenesis bioassay (Experiment 1) and an in vivo liver initiation assay (Experiment 2) in rats. Vol. 37 No. 5 kit (Vector Laboratories Burlingame, CA, USA) was used. Endogenous peroxidase was inhibited by incubation with freshly prepared 0.3% hydrogen peroxide with methanol for 30 min. The sections were incubated overnight with rabbit polyclonal anti-glutathione S-transferase placental form (GST-P) antibody (Medical & Biological Laboratories, Nagoya, Japan; 1:1,000), mouse monoclonal anti-proliferative cell nuclear antigen (PCNA) antibody (DAKO, Glostrup, Denmark; 1:800) and mouse monoclonal anti-cyclooxygenase-2 (COX-2) antibody (BD Biosciences, Tokyo, Japan; 1:250, Experiment 1 only) at 4°C, followed by incubation with a biotinylated secondary antibody for 30 min and with avidin peroxidase conjugate for 30 min at room temperature. The sections were then developed in 0.05% 3, 3'-diaminobenzidine/hydrogen peroxide as the chromogen. For PCNA staining and COX-2 staining, the deparaffinized tissue sections were placed in an antigen-retrieval solution (0.01 M citrate buffer, pH 6.0) for 20 min in a hot bath at 60°C or autoclaved at 121°C for 10 min prior to immunohistochemical staining. After staining, the slides were lightly counterstained with hematoxylin. The numbers and areas of GST-P-positive foci ( 0.2 mm in diameter) and total areas of the liver sections were quantified using WinRoof software (v5.7.2; Mitani Corp., Fukui, Japan). The number of PCNA-positive cells and COX-2-positive cells counted under × 200 magnification, was expressed as a percentage of the total cells or area counted in 20 randomly selected fields (including foci). In both analyses, cranial and caudal parts of the right lateral liver lobe were used. Suzuki et al. (2010) showed that the intralobular difference of GST-P-positive foci expression is related to the MeIQx-hepatocarcinogenesis. Therefore, for the determination of intralobular differences of GST-P-positive foci expression in the liver of Experiment 2, we defined the GST-P-positive foci adjacent to Glisson's sheath as zone 1, adjacent to the central vein as zone 3, and adjacent to both Glisson's sheath and the central vein, or not adjacent to either of them, as zone 2, using the method described by Suzuki et al. (2010) .
Definition of zones in the liver
cDNA microarray analysis
Total RNA of the liver obtained from Experiment 1 was extracted with an RNeasy Mini Kit (QIAGEN, Hilden, Germany), in accordance with the manufacturer's instructions. Using 10 μg of total RNA from one animal from each of the controls, 138 mg/kg OPZ, 0.125% BNF and 138 mg/kg OPZ+0.125% BNF groups, double-stranded cDNA was synthesized with an Invitrogen Superscript Double-Stranded cDNA Synthesis kit (Invitrogen Corp., CA, USA), in accordance with the manufacturer's protocol. After labeling with Cy3, 6 μg of each of the Cy3-labeled cDNA sample were loaded onto a Rattus norvegicus Roche NimbleGen Microarray for Gene Expression (Roche NimbleGen: Euk Expr 385K catalog Arr, 26,739 targets/microarray). Using the robust multiple average normalization method (Irizarry et al., 2003) , differentially expressed genes were analyzed. Gene information was retrieved from the National Center for Biotechnology Information website (http://www.ncbi.nlm.nih.gov).
Real-time RT-PCR analysis
Total RNA of the liver obtained from Experiment 1 was extracted with an RNeasy Mini Kit (QIAGEN), in accordance with the manufacturer's instructions. Reverse transcription was carried out with 2 μg RNA for cDNA synthesis using a Thermoscript RT-PCR System kit (Eppendorf Co., Ltd., Tokyo, Japan), in accordance with the manufacturer's protocol. Quantitative real-time RT-PCR with Power SYBR Green PCR Master Mix (Applied Biosystems Japan Ltd., Tokyo, Japan) was performed using a StepOnePlus™ Real-time PCR System (Applied Biosystems Japan Ltd.). The PCR primers (listed in Table 1) were designed using Primer Express software (Version 3.0; Applied Biosystems Japan Ltd.). The amount of target gene expression was normalized to an endogenous reference (actin, beta) and relative to a control was obtained using the 2 -ΔΔCt method (Livak and Schmittgen, 2001 ).
Lipid peroxidation levels
Oxidative lipid peroxidation was estimated using TBARS. Hepatic TBARS levels were determined using the method described by Ohkawa et al. (1979) with a slight modification. The liver tissue samples (approximately 50 mg) obtained from Experiment 1 were homogenized in 450 μl of buffer (containing 50 mM Tris-HCl; pH7.4, 1.15% KCl, 0.2 mM EDTA, 0.1 mM dithiothreitol (DTT), 0.1 mM Protease Inhibitor Cocktail and 20% glycerol) using TissueLyser (QIAGEN). Aliquots of 3 mg of liver homogenates were mixed with 0.2 ml of 8.1% sodium dodecyl sulfate and 3 ml of 0.4% thiobarbituric acid in 10% acetic acid (pH 3.5), heated at 95°C for 60 min and then cooled. Each reaction mixture was centrifuged at 4,000 rpm for 10 min after adding 1 ml of distilled water and 5 ml of n-butanol and pyridine (15:1, v/v). The absorbance of the resulting solution was determined spectrophotometrically at 532 nm, using a Synergy HT Multi-Detection Microplate Reader (BioTek, Winooski, VT, USA). The TBARS levels were expressed as the equiva- Vol. 37 No. 5 lents of malondialdehyde (MDA) amounts that were produced from 1,1,3,3,-tetramethoxypropane.
Preparation of microsomal fraction
The microsomal fractions were obtained according to the methods described by Yoshihara et al. (2001) . Liver tissue samples (approximately 100 to 130 mg) obtained from Experiment 2 were homogenized in 700 μl of icecold buffer (containing 50 mM Tris-HCl; pH 7.4, 1.15% KCl, 0.2 mM ethylene diamine tetra-acetic acid, 0.1 mM DTT, 0.1 mM Protease Inhibitor Cocktail and 20% glycerol) using a pestle. The homogenate was centrifuged at 700 × g for 10 min at 4°C, and the supernatant was centrifuged at 10,000 × g for 20 min at 4°C. The 500 μl of supernatant was ultracentrifuged at 105,000 × g for 90 min.
The microsomal pellet was resuspended in microsome buffer, and the protein content of the homogenate was measured using the BCA Protein Assay Kit (Pierce, IL, USA), with bovine serum albumin as a standard.
Microsomal reactive oxygen species production
NADPH-dependent microsomal ROS production was determined by measuring the oxidation of 2',7'-dichlorodihydrofluorescein diacetate (H 2 DCFDA) to its fluorescent product 2',7'-dichlorofluorescein in liver microsomes according to the methods described by Schlezinger et al. (1999) . The microsomes (final concentration 0.2 mg/ml) obtained from Experiment 1 were incubated in the dark at 37°C for 30 min in 50 mM Tris-HCl (pH 7.4) and 5 μM H 2 DCFDA. In addition, 2.5 mM β-NADPH was added. In some cases, 0.1 mM SKF-525A (Toronto Research Chemicals, ON, Canada), a well-known inhibitor of CYP, and 0.1 mM H 2 O 2 as a positive control were added to the wells. The fluorescence was monitored every 5 minutes over 2 hr using a Synergy HT MultiDetection Microplate Reader (BioTek) with excitation and emission wavelengths of 485 and 528 nm, respectively. The data were then normalized to the control values, with the control expressed as a value of 100%.
Plasma concentration of OPZ and BNF
To measure the plasma concentration of OPZ and BNF, the HPLC system (Waters chromatography division, Milford, MA, USA) was used in Experiment 1. Blood samples were collected from three rats each in the High OPZ, High BNF and OPZ+BNF groups. The blood sampling was performed one hour after administration of OPZ during the morning time. Chromatographic separation of OPZ or BNF was achieved using a Cadenza CD-C18 (3 μm, 4.6 mm I.D. × 150 mm, Imtakt) reverse phase analytical column. The mobile phase consisted of a mixture of 10 mmol/l phosphate buffer/acetonitrile (13:7, v/v adjusted pH to 7.3 with triethylamine) or a mixture of acetonitrile/25 mmol/l potassium dihydrogen phosphate (7:3, v/v). The mobile phase was pumped at an isocratic flow rate of 1.3 ml/min at 40°C or 1.5 ml/min at 40°C. The wavelength of UV detection was set at 302 and 285 nm for OPZ and internal standard solution (IS) (Lansoprazole: LPZ) assays, respectively or 274 nm for BNF and IS (hexyl 4-hydroxybenzoate) assays.
Plasma samples were collected at an hour after a final oral dose of OPZ. Plasma samples (400 μl) were transferred to a 15 ml glass tube, and 160 μl of diluent, 10 mmol/l disodium hydrogen phosphate for the OPZ assay, or a mixture of water/acetonitrile (1:1, v/v) for the BNF assay, was added. Then 40 μl of IS working solution (5 μg/ml) was spiked. A 2 ml aliquot of extraction solvent, tert-butyl methyl ether, was added and the sample was shaken for 10 min before being centrifuged for 3 min at 3,000 rpm. The organic layer (1.5 ml) was quantitatively transferred to a 6 ml glass tube and evaporated under a stream of nitrogen. The dried extract was then reconstituted with 200 μl of mobile phase, and a 20 μl aliquot was injected into chromatographic system.
For calibration samples, to 400 μl of blank rat plasma, 160 μl of working standard of OPZ or BNF was added, yielding final concentrations of 20-2,000 ng/ml of OPZ and BNF. To this mixture, 40 μl of IS working solution was added to yield IS concentration of 500 ng/ml.
Statistical analysis
All data were expressed as mean with standard deviation. Numerical data were evaluated using the following methods: A Bartlett's test for equal variance was used to determine if the variance was homogenous between the groups. If the variance was homogenous, numerical data were assessed using Dunnett's multiple comparison test. If a significant difference in variance was observed, the Steel test was used instead. In addition, to estimate the modifying effect of the combined administration, statistical analysis was performed using the method recommended by Futakuchi et al. (1996) and Hasegawa et al. (1991) .
RESULTS
Experiment 1 Body and liver weights, food intake and BNF intake
In all treated groups, body weight significantly decreased when compared with the DEN alone group (Table 2 ). In the OPZ+BNF group, body weight significantly decreased when compared with other treated groups.
The absolute and relative liver weights significantly increased in the treated groups when compared with the DEN alone group. The relative liver weight in the OPZ+BNF group was approximately 1.8-fold higher than that in the DEN alone group, and was significantly higher than the High OPZ or High BNF groups (Table 2) .
Food intake did not fluctuate with the treatment of OPZ or BNF, and average BNF intakes were 0.08 ± 0.01, 0.17 ± 0.01 and 0.09 ± 0.01 g/kg body weight/day in the Low BNF, High BNF and OPZ+BNF groups, respectively. The food efficiency in the DEN alone group, Low/High OPZ, Low/High BNF and OPZ+BNF groups was 0. 17, 0.15, 0.15, 0.19, 0.16 and 0.11, respectively . A decreasing tendency of food efficiency was observed in the Low/ High OPZ, High BNF and OPZ+BNF groups when compared to the DEN alone group.
Histopathology, GST-P-positive foci and PCNA-positive cells in the liver
Histopathologically, both OPZ and BNF induced diffuse hepatocellular hypertrophy with eosinophilic cytoplasm. Foci of cellular alterations of clear cells, eosinophilic cells and basophilic cells were observed in the treated groups. There was no inflammatory change in the OPZ, BNF and OPZ+BNF groups. Immunohistochemical analysis revealed that the number/area of GST-P-positive foci significantly increased in the treated groups (Table 2, Figs. 2a and b). In the OPZ+BNF group, the number of Table 2 . Final body and liver weights, food intake, BNF intake, number/area of GST-P-positive foci, PCNA-positive cells, ROS production and TBARS in the liver of male F344 rats given OPZ and/or BNF for 6 weeks after DEN treatment GST-P-positive foci significantly increased when compared with the OPZ treated and BNF treated groups, and the area of GST-P-positive foci significantly increased when compared with the OPZ treated groups. Meanwhile, the number of PCNA-positive cells significantly increased in the OPZ+BNF groups when compared with the DEN alone group (Table 2) .
DNA microarray and real-time RT-PCR analyses
Hepatic gene expression changes in rats from the DEN alone, Low OPZ, Low BNF and OPZ+BNF groups were screened using an oligonucleotide microarray. In the microarray, 4,439 genes showed more than a 2-fold increase or more than a half-fold decrease in their expression in one rat each from the OPZ, BNF and OPZ+BNF groups when compared with a rat of the DEN alone group (supplementary data). We focused on the AhR battery and oxidative stress response-related genes. Real-time RT-PCR analysis on the genes listed in Table 1 was performed using liver samples (6 rats/group) ( Table 3) .
In real-time RT-PCR analysis, the expression of Cyp1a1, Cyp1a2, Cyp1b1, Ugt1a6 and Nqo1, which are phase I metabolic enzymes and are regulated by AhR, significantly increased in the treated groups when compared with the DEN alone group. Of these genes, the expression of Cyp1a2, Cyp1b1, Ugt1a6 and Nqo1 significantly increased in the OPZ+BNF group when compared with the Low OPZ or Low BNF groups (Table 3 ). The expression of Aldh1a1 and Cyp2b2 significantly increased in the OPZ treated groups, but showed a decreasing tendency in the OPZ+BNF group when compared with the OPZ treated group. On the other hand, Aldh3a1 significantly increased in the BNF treated groups when compared with the DEN alone group, and significantly increased in the OPZ+BNF group when compared with the Low OPZ or Low BNF groups. In addition, the expression of Ahrr significantly increased in the BNF and OPZ+BNF groups, and significantly increased in the OPZ+BNF group when compared with the OPZ and BNF treated groups.
In phase II metabolic enzymes, the expression of Akr7a3, Gpx2, Yc2 and Me1 significantly increased in the treated groups when compared with the DEN alone group. Of these genes, Gpx2 and Yc2 significantly increased in the OPZ+BNF group when compared with the Low OPZ or Low BNF groups. The expression of Akr7a3 and Me1 in the OPZ+BNF group showed an increasing tendency when compared with the Low OPZ or Low BNF group (Table 3) .
In inflammation-related genes, the expression of Cox2, Serpine1, Mmp12 and Fgf21 significantly increased in the BNF treated groups when compared with the DEN alone groups, and significantly increased or showed an increasing tendency in the OPZ+BNF group when compared with the other treated groups. The expression of Il-6 showed an increasing tendency in the OPZ+BNF group when compared with the DEN alone group. The expression of Nfkb1 and Nfkbia did not fluctuate in the treated groups but the expression of Tnf significantly increased in the High BNF group (Table 3) .
In cell cycle-related genes, the expression of Chek1 Number and area of GST-P-positive foci in rats given OPZ and/or BNF after DEN initiation. Each bar shows the number (A) and area (B) of GST-P-positive foci in the liver of rats given DEN alone (DEN alone), 138 mg/kg OPZ (Low OPZ), 276 mg/kg OPZ (High OPZ), 0.125% BNF (Low BNF), 0.25% BNF (High BNF) or 138 mg/kg OPZ+0.125% BNF (OPZ+BNF). * , ** significantly different from the DEN alone group at P < 0.05 or P < 0.01, respectively. ## significantly different from the OPZ+BNF group at P < 0.01. (Table 3) . In other genes, the expression of Myc significantly increased in the OPZ and OPZ+BNF groups when compared with the DEN alone group (Table 3) .
Microsomal ROS production
To estimate the cellular sources of ROS, NADPHdependent ROS production was measured in liver microsomes. The oxidized indicator was not detected in the absence of NADPH. With the addition of NADPH into the microsomal system, ROS production was dramatically enhanced, but ROS production significantly decreased in the OPZ treated, high BNF and OPZ+BNF groups when compared with the DEN alone group (Table 2) . SKF-525A, a well-known inhibitor of CYP, inhibited NADPHdependent ROS production.
Oxidative stress on cellular membrane
To evaluate whether oxidative damages to cellular components occurred, TBARS formation was determined in the liver. There was no remarkable change in TBARS content between the groups (Table 2) .
Immunohistochemistry of COX-2 in the liver
COX-2-positive cells, which are recognized as Kupffer cells, were observed in the sinusoid of the livers (Fig. 3) . COX-2-positive cells were mainly observed in the periportal areas of the liver in the DEN alone group, but were scattered throughout the liver in the BNF and OPZ+BNF groups. In addition, COX-2-positive Kupffer cells were observed in the periphery of some foci of the OPZ+BNF group (Fig 4) . The number of COX-2-positive cells in the OPZ+BNF group significantly increased when compared with the DEN alone group (Fig. 3) .
Plasma concentration of OPZ and BNF
We estimated the plasma concentration of OPZ and BNF at necropsy (Table 4 ). In the High BNF and OPZ+BNF groups, the plasma concentration of BNF could not be detected (less than the limit of quantitation: 20 ng/ml). However, the concentration of OPZ was 6,053 ± 2,409 ng/ml in the High OPZ group and 310 ± 241 ng/ml in the OPZ+BNF group.
Experiment 2 Body and liver weights
In all groups, no significant changes in body weights were observed in the treated groups when compared with the MeIQx alone group (Table 5) . Absolute liver weights significantly increased in the High BNF group, and relative liver weights significantly increased in the High BNF and OPZ+BNF groups when compared with the DEN alone group (Table 5 ). The relative liver weights in the OPZ+BNF group significantly increased when compared with the Low OPZ group.
Histopathological examinations and GST-P-positive foci in the liver
Immunohistochemical analysis revealed that the number and area of GST-P-positive foci significantly increased only in the Low BNF group, but not in the High BNF and OPZ+BNF groups ( Table 5 ). Because of there being no dose-relationship in the induction of GST-P-positive foci in BNF treated groups, it was concluded that BNF did not have liver initiation activity. No apparent difference in the localization of GST-P-positive foci with respect to zones 1-3 was observed among the groups. There was no change in the number of PCNA-positive cells among the groups (Table 5) .
DISCUSSION
It has previously been demonstrated that the simultaneous administration of several chemicals induced additive or synergistic effects on the carcinogenicity in rats (Hasegawa et al., 1989 P) and N-ethyl-N-hydroxyethylnitrosamine at low doses resulted in synergistic effects in the rat liver (Hasegawa et al., 1989) . In addition, in the two-stage forestomach carcinogenesis model, the combined administration of promoters/carcinogens exerted a strong enhancing influence on the forestomach carcinogenesis in rats, although the low doses of them did not have a significant promoting activity (Hirose et al., 1991) . Synergism occurs when the effect of two or more substances acting together exceeds the sum of their effects when acting separately (Reif et al., 1984) . Hasegawa et al. (1991) examined potential synergism between five HCAs (3-amino-1-methyl- In their report, a heteroadditive model was used, and net values were obtained by subtracting the control value (DENalone group). In the heteroadditive model, they compared the net value for the combined treatment and the sum of the net value of individual treatment at 1/5 dose, and the net value for the combined treatment was greater than the sum of net values in 1/5 dose. They concluded that the combination effects were synergistic. However, dose-response curves were not considered in this model. Reif (1984) pointed out the importance of the dose response curve in the analysis of the combined effects, and described that in ordinary heteroadditive methods the combined effect could be evaluated whether it was synergistic or not. In this heteroadditive model, the consideration of the dose response curves was lacking. On the other hand, Hasegawa et al. (1994 Hasegawa et al. ( , 1995 examined the combination effect of ten HCAs at low doses using two statistical models, a heteroadditive model and an isoadditive model. In the heteroadditive model, significant greater effects were found in the combination group. On the other hand, in the isoadditive model, Hasegawa et al. (1994 Hasegawa et al. ( , 1995 compared the average value of individual treatments of 1/1 dose and the value of ten heterocyclic amines and the combination treatment at 1/10 dose. As a result, since a significant increase was not shown in the combination group, they concluded that this combination effect was not synergistic in the isoadditive model. Futakuchi et al. (1996) examined potential synergism between four N-nitroso compounds (nitrosomorpholine, nitrosodimethylamine, nitrosodiethanolamine, and nitroso-oxazolidine) in rat liver carcinogenesis in a medium-term bioassay where male F344 rats were initially given DEN, and 2 weeks later received test chemicals for a period of 6 weeks at a full or l/4 dose of that proven to be carcinogenic, individually or in combination. In their report, the effect value of individual chemicals was obtained by subtracting the control value (DENalone group). In the heteroadditive model, they compared the sum of the effect values of each individual treatment at 1/4 dose and the value for rats treated with four chemicals in combination at the 1/4 dose level, and no significant increase was observed between them. However, in the isoadditive model, the value in combination at the 1/4 dose level treatment was almost the same as the average of four individual treatments at full dose and, the value in combination at 1/16 dose level treatment were not significantly higher than the average value of four individual treatment at 1/4 dose. They concluded that the combined effects were not synergistic but isoadditive. In the present study (Experiment 1), we demonstrated that the combined administration of low doses of OPZ and BNF induced higher numbers of GST-P-positive foci when compared with the high doses of OPZ or BNF, and induced higher areas of GST-P-positive foci when compared with high dose of OPZ. In the heteroadditive model, the effect value of the combination at a low dose (area, 0.67 mm 2 /cm 2 ; number, 8.08 number/cm 2 ; average of value of OPZ+BNF minus value of DEN-alone) was not significantly higher than the sum of the effect value of both OPZ and BNF at low dose (area, 0.55 mm 2 /cm 2 ; number, 5.34 number/cm 2 ). However, in the isoadditive model, the value of the combined administration of low doses of OPZ and BNF (area, 0.82 ± 0.34 mm 2 /cm 2 ; number, 10.66 ± 2.76 number/cm 2 ) was significantly higher (P < 0.05, t test) than the average value of each individual treatment at a high dose of OPZ and BNF (area, 0.50 ± 0.27 mm 2 /cm 2 ; number, 6.53 ± 2.40 number/cm 2 ; average of value of High OPZ and value of High BNF). Therefore, it can be concluded that the combined liver tumor promotion effect of OPZ and BNF is synergistic in the isoadditive model. In Experiment 1, phase I metabolic enzymes such as Cyp1a1, Cyp1a2, Cyp1b1, Nqo1 and Ugt1a6, which are called as AhR gene battery and induced by AhR, significantly increased or showed an increasing tendency in the OPZ+BNF group when compared with the Low OPZ or Low BNF group. Aryl-hydrocarbon receptor repressor (AHRR) is activated by the AhR ligand in heterodimer with aryl hydrocarbon receptor nuclear translocator (ARNT), and expressed AHRR inhibits the AhR function (Brauze et al., 2006) . AhR and AHRR constitute a negative regulatory feedback loop of xenobiotic signal transductions (Brauze et al., 2006) . In the OPZ+BNF group, the expression of Ahrr significantly increased or showed an increasing tendency when compared with the treated groups, suggesting the enhanced transduction of AhR. In addition, phase II metabolic enzymes such as Akr7a3, Gpx2, Yc2 and Me1 significantly increased in the treated groups, and significantly increased or showed an increasing tendency in the OPZ+BNF group when compared with the other treated groups. Nrf2 is activated by oxidative stress and induces detoxification enzymes and antioxidants (Köhle and Bock, 2007) . It is generally accepted that the microsomal electron system, including CYPs and NADPH-CYP reductase generates ROS through the metabolism, with the subsequent formation of an oxygenated substrate and water (Poulos and Raag, 1992) . Although electron transfer is normally a well-coupled process, superoxide and H 2 O 2 may be released in Vol. 37 No. 5 the presence of CYP1A inducers that are poorly metabolized (Puntarulo and Cederbaum, 1998; Nishikawa et al., 2002) . Therefore, upregulation of these genes suggests that the increment of ROS production contributes to the enhancement of the liver tumor promoting effect in the OPZ+BNF group. However, microsomal ROS production significantly decreased in the OPZ+BNF group, and no fluctuations of TBARS were observed in the treated groups. Oxidative stress usually occurs when ROS production in cells or tissues exceeds the antioxidant potential (Klaunig et al., 1998) . Therefore, it is possible that the antioxidant regulated by Nrf2 probably exceeds the ROS production and removes the ROS generated in the OPZ+BNF group.
It has been demonstrated in our previous studies that COX-2 is related to the liver tumor promoting effect of BNF (Shimada et al., 2010; Kuwata et al., 2011) . COX-2 may be involved in the early stage of hepatocarcinogenesis, and the increased expression of COX-2 in noncancerous liver tissues has been significantly associated with shorter disease-free survival in patients with hepatocellular carcinomas (Cervello and Montalto, 2006) . In tumors in human, overexpression of COX-2 leads to an increase in prostaglandin (PG) levels which affects many mechanisms involved in carcinogenesis, such as angiogenesis, inhibition of apoptosis, and stimulation of cell growth, as well as invasiveness and the metastatic potential of tumor cells (Cervello and Montalto, 2006) . Several reports suggest that OPZ might have an anti-inflammation effect (Kedika et al., 2009; Shivanna et al., 2011) . Indeed, OPZ inhibited ROS production and protected against oxidative stress by inducing heme-oxygenase-1 (Kedika et al., 2009; Shivanna et al., 2011) . However, the ligands of AhR, including TCDD and B[a]P, induced Cox-2 expression (Degner et al., 2007 and . TCDD and B[a]P induced transcription activity of COX-2 in breast cancer MCF-7 cells (Degner et al., 2007) . Furthermore, the TCDD-association of AhR to xenobiotics responsive elements in the Cox-2/Cyp1a promoter was inhibited by AhR antagonists such as 3,3'-diindolulmetahane and resveratrol (Denger et al., 2007) . On the other hand, TCDD increases the intracellular concentration of free Ca 2+ and subsequently activates cytosolic phospholipase A2 and additional inflammatory marker, Cox-2, expression in U937 macrophages (Sciullo et al., 2008) . In the present study, the expression of Nfkb1, Nfkbia and Tnf, which are regulated by Nfkb, did not fluctuate in the OPZ+BNF group. However, the expression of Cox-2 significantly increased in the OPZ+BNF group when compared with the DEN alone group, and COX-2 protein also significantly increased in this group. Therefore, these data indicate that the activation of AhR contributes to the enhancement of COX-2, and it can be suggested that the combined administration of OPZ and BNF, which are the ligands of AhR, may induce COX-2 via AhR and enhance the liver tumor promoting effect in rats. On the contrary, the induction of Cyp1a by AhR was induced in hepatocytes, but it is not clear whether the induction of Cox-2 in Kupffer cells occurred in the same mechanism. Recently, it has been reported that tumor microenvironment is related to the hepatocarcinogenesis (Yang et al., 2011) . Kupffer cells induce programmed death ligand-1, which impairs cytotoxic CD8 + T cell function in human hepatocellular carcinomas (Yang et al., 2011) . Kupffer cells also produce IL-6 and osteopontin that play a pivotal role in various cell signaling pathways promoting inflammation, tumor progression and metastasis. Therefore, Kupffer cells expressing COX-2 might have been related to the liver tumor promoting effect.
CHEK1 is phosphorylated in response to DNA damage and is essential for cell-cycle arrest in response to DNA damage or DNA replication blockage (Niida and Nakanishi, 2006) . WEE1 is a tyrosine kinase that controls the cell cycle in response to DNA damage (Raleigh and O'Connell, 2000) . When DNA damage is induced in the G2 phase, Wee1 phosphorylates cyclin-dependent kinase 2 (cdc2) and inactivates cdc2, and prevents the entry into mitosis phase (Raleigh and O'Connell, 2000) . OPZ showed a weak genotoxicity in primary rat hepatocytes (Martelli et al., 1998) . In the present study, the expression of Chek1 and Wee1 significantly increased in the OPZ+BNF group when compared with the DEN alone group. In addition, the expression of Myc significantly increased in the OPZ treated and OPZ+BNF groups. Myc has a neoplastic potential and plays an important role in regulating cell proliferation (Dang, 1999) . Impaired expression of Myc is related to the development of many malignant tumors in humans and animals (Hoffman and Liebermann, 1998) . OPZ has a liver tumor promoting effect in rats, but the mechanism is not clear. Taking into account these points, it can be considered that the involvement of DNA damage and increased expression of Myc are related to the enhancement of liver tumor promoting effects of OPZ and BNF, although further study is needed.
The plasma concentration of BNF could not be detected. However, the concentration of OPZ was 6,053 ± 2,409 ng/ml in the High OPZ group and 310 ± 241 ng/ml in the OPZ+BNF group. OPZ is metabolized via hepatic CYP1A1/2, 2D1, 3A1/2 in rats (Lee et al., 2009 ). In the OPZ+BNF group, the expression of Cyp1a1 and 1a2 increased when compared with the Low OPZ and Low BNF groups. This finding suggests that the induction of liver drug-metabolizing enzyme by BNF may affect the metabolism of OPZ in the OPZ+BNF group. It has previously been shown that the plasma concentration of BNF reaches a maximal level at 80-120 min and then starts declining toward a lower plateau value in SD rats given a continuous intravenous infusion of 1.5 or 6 mg/kg/hr BNF for 6 hr (Chen et al., 2010) . BNF is known as a substrate of CYP1A enzymes and the BNF clearance increases with time after continuous intravenous infusion to rats (Chen et al., 2010) . Such a time-dependent increase in clearance supports the present finding of plasma BNF concentrations not being detected in BNF treated rats. In addition, the exponential increase of plasma concentration of OPZ was not observed with the combined administration of OPZ and BNF. On the other hand, the expression of Cyp1a1 in the 0.5% BNF group was 299-fold higher than that of the DEN alone group when they were fasted for 12 hours (Shimamoto et al., 2011b) , while the expression of Cyp1a1 without fasting in the 0.25% BNF group of our study was 3357-fold higher than that of the DEN alone group. Therefore, since the expression of genes such as Cyp1a1 and Cyp1a2 significantly increased in the OPZ+BNF group, it is likely that some unknown metabolic effect due to the combined administration intensifies the liver tumor promoting effect.
MeIQx is activated by CYP1A2, and the metabolites produced are highly reactive and bind covalently to DNA (Yamazoe et al., 1988) . Previous reports have shown that CYP1A2 inducers such as fenbendazole and caffeine did not enhance the MeIQx-induced hepatocarcinogenesis in rats (Suzuki et al., 2002; Kuribayashi et al., 2006) . It has also been reported that BNF did not enhance the MeIQxinduced hepatocarcinogenesis in rats . In that study, CYP1A expression was mainly observed in the area adjacent to the central veins (zone 3) of the liver, where GST-P-positive foci were preferentially located, in MeIQx-treated rats; while BNF treatment induced CYP1A in the area adjacent to Glisson's sheath (zone 1). Taken into account the distribution differences of the CYP1A induction between MeIQx and BNF, Suzuki et al. (2010) speculated that the difference of CYP1A expression may be related to MeIQx-induced hepatocarcinogenesis. In the present study, no apparent difference in distribution of GST-P-positive foci was observed among the groups. Although CYP1A2 activates MeIQx, CYP1A1 is thought to be related to the detoxification of MeIQx (Suzuki et al., 2002) . Indole-3-carbinol, which is a chemopreventive compound, preferentially induces CYP1A1 rather than CYP1A2 and inhibits the HCA-induced carcinogenicity by shifting the metabolism of HCAs (Hirata et al., 2008) . In our previous studies, OPZ and BNF also induced expression of both Cyp1a1 and Cyp1a2 in rats, and preferentially induced Cyp1a1 rather than Cyp1a2 (Hayashi et al., 2012a (Hayashi et al., , 2012b . In addition, the expression of NATs in the liver did not fluctuate with the administration of BNF (Suzuki et al., 2002) . Because MeIQx is activated by NAT, no induction of NAT may result in the unchanged initiation activities. In the present study, no enhancement of MeIQx-induced hepatocarcinogenesis was observed in the OPZ+BNF group, although the number and area of GST-P-positive foci increased in the Low BNF group but not in the High BNF group. Therefore, enhanced liver initiation activity may not be induced by the treatment of two different chemicals that have similar capabilities to induce both CYP1A1 and CYP1A2.
In conclusion, the co-administration of OPZ and BNF resulted in an enhanced liver tumor promoting effect but not liver initiation activity in rats. The outcome of the present study suggests the possibility that the combined liver tumor promotion effect of two different compounds that have similar capabilities to induce CYP1A is synergistic. Currently, regulatory agencies in individual countries set the acceptable daily intake for chemicals in food. However, particular attention should be paid to the combined exposure of plural chemicals in food that are recognized as CYP inducers. In order to eliminate the enhanced adverse effects from simultaneous exposure to plural chemicals that have the capability of inducing CYPs, we must reconsider the risk evaluation of these chemicals. As our data are limited to the combined administration of OPZ and BNF only, further examination using other CYP inducers is vital.
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